S Carson Callahan
Overview
Explore the profile of S Carson Callahan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Jagodinsky J, Callahan S, Minne R, Johnson D, Tomlins S, et al.
JCO Precis Oncol
. 2025 Feb;
9:e2400690.
PMID: 39983077
Purpose: Metastatic spread of non-small cell lung cancer (NSCLC) to the brain is a commonly occurring and challenging clinical problem, often resulting in patient mortality. Systemic therapies including immunotherapy have...
2.
Tomczak K, Patel M, Bhalla A, Peterson C, Landers S, Callahan S, et al.
Mol Carcinog
. 2024 Nov;
64(1):44-56.
PMID: 39600120
Malignant peripheral nerve sheath tumor (MPNST) development is characterized by an altered DNA methylation landscape, which presents a promising area for developing MPNST-specific biomarkers for screening patients with NF1. Genome-wide...
3.
Bakhtiar H, Sharifi M, Helzer K, Shi Y, Bootsma M, Shang T, et al.
NPJ Precis Oncol
. 2024 Oct;
8(1):220.
PMID: 39358429
In preclinical studies, p53 loss of function impacts chemotherapy response, but this has not been consistently validated clinically. We trained a TP53-loss phenocopy gene expression signature from pan-cancer clinical samples...
4.
Sharifi M, Shi Y, Chrostek M, Callahan S, Shang T, Berg T, et al.
JCI Insight
. 2024 Sep;
9(18).
PMID: 39315546
Therapies against cell-surface targets (CSTs) represent an emerging treatment class in solid malignancies. However, high-throughput investigations of CST expression across cancer types have been reliant on data sets of mostly...
5.
Callahan S, Kochat V, Liu Z, Raman A, Divenko M, Schulz J, et al.
Front Cell Dev Biol
. 2022 Aug;
10:936168.
PMID: 35927986
Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease with significant mortality and frequent recurrence. Prior efforts to transcriptionally classify HNSCC into groups of varying prognoses have identified...